Evidence map›Paper›PMID 30484985›Full record

SynthesisAsian Pacific journal of cancer prevention : APJCP2018

Determining the Survival Rate of Colorectal Cancer in Iran: A Systematic Review and Meta-Analysis

Bahram Tahmasbi, Ghasem Abedi, Mahmood Moosazadeh, Ghasem Janbabai, Fereshteh Farshidi, Kamyar Mansori, Yousef Moradi, Fatemeh Khosravi Shadmani, Serveh Parang, Zaher Khazaei

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Asian Pacific journal of cancer prevention : APJCP, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Evaluation of CD10 expression as a diagnostic marker for colorectal cancer.Gastroenterology and hepatology from bed to bench · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Bahram TahmasbiHealth Sciences Research Center, Departman of Public Health, Mazandaran University of Medical Sciences, Sari, Iran. Email: iq134589@yahoo.com
Ghasem Abedi
Mahmood Moosazadeh
Ghasem Janbabai
Fereshteh Farshidi
Kamyar Mansori
Yousef Moradi
Fatemeh Khosravi Shadmani
Serveh Parang
Zaher Khazaei
Mazandaran University of Medical Sciences · IRDezful University of Medical Sciences · IRIran University of Medical Sciences · IRKurdistan University of Medical Sciences · IRSabzevar University of Medical Sciences · IRShahid Beheshti University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Colorectal cancer is one of the most common causes of death in the world. Despite of remarkable advances in medical sciences, cancer is an important disease and the second cause of death after cardiovascular diseases. The present study was aimed at determining the survival rate of colorectal cancer in Iran. Methods: The present study is a systematic review of national and international electronic databases. Studies that had the inclusion criteria were included in the study, electronically published articles over December 2007 and March 2015 were retrieved. The collected data were analyzed by meta-analytic method through stata 11.0 Software, and the survival rate was measured. Results: The 1-, 2-, 3-, 4-, and 5-year survival rates of colorectal cancer in Iran were respectively calculated as 85, 75.10, 65, 55.40, and 52.The results indicated that there is a significant relationship between anatomic location of tumor and survival rate. According to the results of this examination, survival rate of the patients with rectal cancer was 41.9 times higher than those with colorectal cancer. Conclusion: Due to the relative high prevalence of this cancer among young people in Iran and the low survival rate, early diagnosis of colorectal neoplasms is necessary before they become symptomatic through more effective diagnosis programs of enhancing the patients’ health and survival rate. Moreover, it is necessary to conduct more specialized and relevant studies in order to determine genetic or environmental causes of cancer such as diet and cultural and behavioral habits at the national level and with different ethnicities.

Indexed as

Cardiovascular DiseasesColorectal NeoplasmsDatabases, FactualFemaleHumansIranMaleMiddle AgedPrevalenceSurvival RateColorectal cancerIranmeta- analysissurvival rate

Identifiers

PMID30484985
PMCPMC6318383
OpenAlexW2898749033

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.